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ABSTRACT 
Objective: Use of traditional medicines as aphrodisiac and sex stimulant products is a common phenomenon worldwide as well as in our country. 
In addition to that, in the name of dietary supplements, a number of urban people are using these items as the source of their sex potential. These 
products ought to be responsible for raising several sexual violence and perversion in the society. That’s why these products need to be tested 
whether they contain only natural ingredients or any other allopathic active pharmaceutical ingredients (APIs). 
Methods: High performance liquid chromatography was carried out using a C18 column with a mobile phase composed of (diluted sulfuric acid: 
acetonitrile=60:40) and detected at the wavelength of 290nm. Presence of sildenafil in the identified products was further confirmed by infrared 
(IR) spectroscopy.  
Results: In the study, found that 5 out of 25 traditional medicines and 7 out of 10 dietary supplements contain sildenafil.  In addition to that 4 out of 
total 35 samples were found to contain sildenafil that was exceeding   the highest dose (100mg per dosage unit) recommended by the manufacturer 
(Pfizer, UK) of the brand product ViagraTM. Notably none of the samples were labelled to contain sildenafil. 
Conclusion: About 35% of the market samples were adulterated with sildenafil. The developed method is simple, precise, specific, accurate, robust, 
and cost-effective. Hence it can be used for qualitative and quantitative analysis of sildenafil in falsified market products. 
Keywords: Traditional medicines, Dietary supplements, Sildenafil, IR, HPLC and Validation. 
INTRODUCTION 
Traditional medicines (Unani and Ayurvedic systems) are very 
popular in our country. Though modern healthcare (allopathic) 
facilities are now readily available in the neighborhood, a good 
proportion of our people particularly in the rural and semi-urban 
areas still desire to use this system for their usual ailments such as 
common cold, cough, fever, headache, diarrhea, itching, constipation, 
jaundice, piles and etc. [1]. There is a common belief that these 
products utilize natural ingredients to produce their medicinal 
preparations and people have a general perception that natural 
equates to safe. So, they are free from the potential of side effects. 
These products are advertised as “all natural” but the present study 
had revealed that many of these products contain synthetic 
phosphodiesterase type-5 (PDE-5) inhibitors like sildenafil. 
Manufacturers of these medicines also promote this belief. Taking 
the advantage of general people’s psychology and due to the 
inherent property of natural products to show their efficacy slowly, 
some companies are illegally incorporating pharmaceutical active 
substances and their structurally related analogues with these 
products to win a fast business in the competitive market. No 
toxicological study or clinical trials have been carried out on them, 
thus they can be very dangerous. Besides traditional medicine, use of 
dietary supplements is becoming popular among the people of the 
urban areas along with modern medicine now-a-days from a belief 
that these products contain very necessary ingredients that are 
lacking in the normal diet. But if the manufacturers deliberately add 
APIs in these products for getting specific therapeutic benefits, this 
is again illegal and deceptive to the consumers. On the other hand, if 
these products contain any APIs that are potentially harmful for 
public health, this secret incorporation of APIs in food supplements 
can be considered as a crime. 
Bangladesh government has published separate formularies for all 
the components of Traditional Medicine (e.g. Unani Formulary, 
Ayurvedic Formulary, Homeopathic Formulary etc.) to help 
manufacturers to make products as per the guidelines specific for 
their respective systems. Use of allopathic ingredients (APIs) in 
either of the Unani, Ayurvedic or Homeopathic systems is unlawful  
 
because of these mandatory guidelines. Considering the severe 
adverse effects of the overdose of some APIs, it is a serious potential 
hazard   for   the user of traditional medicines as they might be even 
life-threatening. Regulations for dietary supplements (including 
herbal products) are not the same as those for prescription or over-
the-counter drugs. In general, the regulations for dietary 
supplements are less strict as they require no prescription to buy. 
It had been reported in various journals [2,3,4,5] and 
newspapers[6,7] that some of the allopathic active ingredients 
(APIs) are being used in traditional products unlawfully & 
unethically putting the public health in a state of serious threat. One 
investigation of 2,600 samples by E. Ernst revealed that 24% of 
Chinese herbal remedies in Taiwan were adulterated with at least 
one synthetic medicine [2]. In another survey conducted in USA, 
showed that 7% of their herbal products were adulterated with at 
least one synthetic medicine [3]. 
It is now well established clinically that PDE–5 inhibitors are the 
effective oral treatment of choice for male erectile dysfunction (ED) 
[8,9]. Among the three most popular PDE-5 inhibitors (Sildenafil, 
Tadalafil and Verdenafil) the first developed and consequently the 
most famous and relatively cheap PDE-5 inhibitor is sildenafil, 
approved by the Food and Drug Administration (FDA) in early April, 
1998.The drug was the first oral treatment for men suffering from 
ED. Though ED is uncommon among young men but the indication of 
this drug has raised its recreational use among them over the years 
[10,11,12]. The USFDA had also warned their consumers that there 
is possibility of containing sildenafil or its analogues in any sexual 
enhancement product that claims to work as like as prescription 
drugs [13]. 
Sildenafil Citrate (SC) chemically,1-[4-ethoxy-3-(6, 7-dihydro-1-
methyl-7-oxo-3-propyl-1H-pyrazolo [4,3d] pyrimidin-5-
yl)phenylsulfonyl]-4-methylpiperazine citrate[14], as shown in fig. 1, 
is the active ingredient of the brand product VIAGRATM, is a 
prescription drug for ED patients but not for all [15]. It gives action 
by inhibiting cGMP-specific phosphodiesterase type-5, an enzyme 
that causes degradation of cGMP, which controls blood flow in the 
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penis [8]. Its recommended doses are either 25mg, 50mg or 100mg 
not more than once daily. The drug has a broad profile of side effects 
and adverse effects along with its efficacy like irregular heartbeat, 
shortness of breath, angina, myocardial infarction, stroke, priapism, 
sudden hearing loss and blindness etc. [8]. 
 
Fig. 1: Structural formula of SC 
If this drug is intentionally incorporated in traditional medicines and 
dietary supplements without any labelling unethically, it will put 
public health in a state of serious threat. 
So, in this study an initiative to investigate on this type of 
falsifications in our country has been taken. The objectives of the 
study are: 
 To get an idea on the unethical use of SC in the name of 
traditional medicines and dietary supplements without 
labelling. 
 To identify the products that exceeding the highest dose 
recommended by brand manufacturer Pfizer. 
MATERIALS AND METHODS 
Reagents and Materials 
SC working standard (Source: SMS Pharmaceuticals Limited, India) 
was obtained from ACI Limited, Narayanganj-1400. A total of 35 
market samples were collected randomly from different retail stores 
of Dhaka considering the popularity in the local market in April, 
2013. Among them 25 were traditional medicines and 10 were 
dietary supplements. Out of total 35 samples 18 were tablets/pills, 
15 were capsules and 2 were syrups. All the samples were claimed 
to contain natural ingredients as per their respective formularies. 
The samples were randomly numbered from 1 to 35. All reagents 
like methanol, acetonitrile and water used were of HPLC grade and 
sulfuric acid used were of analytical grade. 
Methods 
Various methods were applied to detect and estimate SC in 
pharmaceutical falsifications. Infrared Spectroscopy [16], Raman 
Spectroscopy [17], HPLC [14, 18, 19], LC-MS [4, 5] techniques were 
developed over the years for this purpose. Among the above 
methods HPLC and IR are the more convenient and cost-effective 
methods for qualitative and quantitative analysis. That’s why this 
study had been designed to develop a simple, precise, specific, 
accurate, robust, cost-effective and validated RP-HPLC method 
according to USP and ICH guidelines [20, 21] to determine the 
presence and amount of SC in traditional products and dietary 
supplements. After that presence of sildenafil in the identified 
products was further confirmed by infrared (IR) spectroscopy. 
Chromatographic Conditions 
Chromatographic Parameters 
A Shimadzu HPLC - Prominence integrated with photo diode array 
detector and degasser was employed to carry out the investigation. 
The chromatographic separation was performed using a Prontosil 
Kromaplus C18, 250 mm length × 4.6 mm internal diameter with 5μ 
or equivalent particle size column. The mobile phase composed of 
diluted sulfuric acid: acetonitrile (60:40, v/v) was pumped at a flow 
rate of 0.5 mLmin-1. The wavelength of detection was set at 290 nm. 
The column temperature was maintained at 30°C. The injection 
volume was set at 10µL. Mobile phase was used as diluting solution 
to prepare both of the standard and test sample preparations. 
Preparation of Mobile Phase 
34 mL of 2N sulfuric acid was taken to a 1000 mL volumetric flask 
containing 566 mL of distilled water. The solution was mixed with 
400 mL of HPLC grade acetonitrile and then sonicated for 15 min 
followed by filtering using 0.2 µm membrane filter.  
Preparation of stock solution of standard 
100 mg working standard of SC was dissolved into 100mL mobile 
phase to give a concentration of 1 mgmL-1. 
Preparation of sample solution 
Approximately 30 mg of sample (enough to give response within the 
linearity range of concentration) was weighed and taken into a clean 
and dry 25 mL volumetric flask. About 15 mL of diluting solution 
was added to it and shaken vigorously to extract the drug from the 
ingredients of the sample. The resulting solution was sonicated for 5 
min. After cooling to room temperature its volume was adjusted up 
to the mark with the same diluting solution. Then different sample 
solutions were injected consecutively in triplicate into the HPLC 
machine and the chromatograms were recorded. Different analytical 
parameters such as linearity, accuracy, specificity, precision, 
robustness, sensitivity (limit of detection and limit of quantification) 
and system suitability were determined to validate the proposed 
method according to ICH guidelines [21]. 
Chromatographic Method Validation Parameters 
Validation of the proposed method was performed [22] using 
standard SC and test sample no. 34. 
System Suitability 
To determine system suitability of the proposed method, at first 
retention time, peak area (%RSD NMT 2.0), theoretical plate (NLT 
3000) and tailing factor (NMT 1.5) of six replicate injections of 
standard SC of 250 µgmL-1 (nominal concentration) were 
determined. Then the percentage of relative standard deviation 
(%RSD) values were determined for each case. 
Linearity 
To determine linearity of the proposed method, five different 
concentrations of SC i.e. 80%, 90%, 100%, 110% and 120% of 
nominal concentration ranging from 200 to 300 µgmL-1 (by diluting 
appropriate amounts of stock solution) were prepared. A calibration 
curve was constructed in the specified concentration range by 
plotting peak area versus concentration. The linear relationship was 
evaluated using the least square method within Microsoft Excel® 
program. 
Specificity 
The specificity of the proposed method was determined by 
comparing the chromatograms of both standard and sample to 
investigate whether there is any interference of unknown excipients 
present in the market samples with the same retention time of SC 
peak. A blank sample was also run to check any interference of it. 
The peak purity tool was utilized to check the purity of both 
standard and sample solution. 
Accuracy 
To determine accuracy of the proposed method, recovery 
experiments were performed by the standard addition method. The 
study was performed by spiking a known concentration of the test 
sample with appropriate concentrations of standard solution to 
produce 80%, 100% and 120% of nominal standard concentration. 
Samples were prepared in triplicate at each levels and the recovery 
percentage was determined.  
Precision 
To analyze precision of the proposed method, intraday precision 
(repeatability) and interday precision (intermediate precision) was 
measured in terms of %RSD of the measurements for both standard 
and market sample solutions in nominal concentration. The analysis 
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was repeated six times on the same day for intra-day precision and 
on two different days for inter-day precision. 
Sensitivity 
Following ICH Q2 (R1) recommendations based on signal to noise 
approach the limit of detection (LOD) was determined for which a 
signal height to noise ratio of 3 was obtained and for limit of 
quantitation (LOQ), a signal height to noise ratio of 10 was obtained. 
Ruggedness 
To determine ruggedness of the proposed method, test sample 
solution was analyzed in six replicates comparing %RSD of the 
measurements by two analysts in the same laboratory. 
Robustness 
To determine robustness of the proposed method, six test sample 
preparations were prepared and analyzed by varying most critical 
analytical parameters while keeping the other parameters 
unchanged. Such as the composition of mobile phase (±5%), flow 
rate (±0.2 mL/min), detection wavelength (±5 nm), column 
temperature (±5°C).  
Analysis by HPLC 
Qualitative Analysis 
Sildenafil appeared as a single peak with a retention time of 
approximately 7 min. It showed maximum absorption of UV light at 
294 nm (from spectrum view extracted from that peak). 
Qualification of sildenafil was performed by comparing the retention 
times of SC single peak of both standard and sample preparations. 
However there is a possibility of appearing a peak for a totally 
different compound with the same retention time like sildenafil due 
to having the same elution rate as sildenafil. To eliminate this type of 
uncertainty, spectrum views (extracted from that peak) in 
ultraviolet-visible (UV) region (200nm - 800 nm) by means of PDA 
detector for both standard and sample preparation were also 
compared in this study. 
Quantitative Analysis 
The quantity of sildenafil in the identified samples was determined 
as concentration (µgmL-1) from the calibration curve, substituting 
the respective peak areas (SC single peak) obtained for the identified 
sample preparations. 
Analysis by IR Spectroscopy 
To assist in the identification of the falsified products IR spectrum of 
sildenafil positive (by HPLC) products were analyzed. IR 
spectroscopy is concerned with the interaction between a molecule 
and radiation from the IR region of the EM spectrum (4000 – 400 
cm-1). IR spectrum can be divided into two approximate regions: 
 Functional group region (4000-1500 cm-1), valuable information 
are obtained from this region to interpret any IR spectrum. 
 Fingerprint region (< 1500 cm-1), usually consists of a very 
complicated series of absorptions that are characteristic for a 
particular compound [23]. 
FT-IR is a very fast technique considering that no further sample 
preparation is needed and spectrum acquisition requires only a few 
seconds. By an accurate comparison between the IR spectrum of any 
sample with that of the original drug it is possible to determine 
whether they have the same composition or not, thus it permits to 
ascertain definitively if the investigated sample is falsified or not. 
In this study, a Shimadzu IR Prestige-21 fourier transformation 
infrared (FT-IR) spectrophotometer was employed for qualitative 
analysis of sildenafil in the identified (by HPLC) market samples. 
Spectra were recorded with 30 scans and a resolution of 2cm-1.The 
approach [24] was: 
Firstly, the IR bands distinct for the reference substance due to its 
functional groups were identified. Each substance has a unique IR 
spectrum.  
Secondly, presence of these distinct bands was searched in the IR 
spectrum of the samples. 
RESULTS AND DISCUSSION 
Chromatographic Method Validation 
System Suitability 
The results are shown in Table 1, indicating good performance of the 
system. 
Table 1: Results of system suitability study for SC 
Chromatographic Parameters Value 
(Mean  ± %RSD) 
Retention time (min) (7.154±0.075) 
Tailing factor (1.387±0.537) 
Theoretical Plate (9486±1.582) 
Peak area (mAU) (5901368±0.273) 
Linearity 
A linear correlation was found between the peak areas and 
concentrations of SC in the concentration range of 200 to 300 µgmL-1 
and the correlation coefficient (R2 = 0.9991) was found highly 
significant. The results of regression analysis were presented in 
Table 2.  
Table 2: Results of linearity study for SC 
Regression Parameters Values 
Regression coefficient (R2) 0.9991 
Slope 24337 
Intercept -139508 
Concentration range(µgmL-1) 200 - 300 
Number of points 5 
Specificity 
HPLC chromatogram of standard SC and sample is showed in fig. 2. 
Standard SC appeared as a single peak with a retention time of 
approximately 7 min. It was found that unknown excipients were 
not interfering with the developed method as no peaks were 
revealed around retention time 7 min and no impurities were 
detected. Moreover the peak purity was 99.99 % which indicates 
that SC is clearly separated from other unknown ingredients of the 
falsified market preparations. 
Accuracy 
The results were shown in table 3, in terms of %RSD of recovery of 
the added standard, indicating good accuracy of the proposed 
method. 
Precision 
The results were presented in terms of %RSD of the measurements 
for intraday and interday variations in table 4, indicating good 
precision of the proposed method. 
Sensitivity 
The values of LOD and LOQ of SC were presented in in table 5 and 
their chromatograms were shown in fig. 3, indicating high sensitivity 
of the proposed method. 
Ruggedness 
The results were shown in table 6, in terms of %RSD of the 
measurements. 
Robustness 
The results were shown in table 7, the proposed method was found 
to be robust with respect of changes in mobile phase composition, 
flow rate, detection wavelength and column temperature. 
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12 out of total 35 samples were found to give response in a zone 
similar to that of standard. The identified samples not only showed a 
peak of same retention time as that of standard but also the same 
pattern in the spectrum view extracted from that peak similar to that 
of standard as represented in the fig. 2. 
Quantitative Analysis 
SC content per dosage unit in the identified samples was 
determined. The results were shown in table 8. 
IR Spectroscopic Analysis 
Comparing the IR spectrum (Fig. 4) with the structure of standard SC 
(Fig. 1), 7 functional groups were identified which were summarized 







Fig.2: Chromatogram of (a) standard SC, (b) Sample no. 9, (c) 
Sample no. 34 
Among the identified groups, the ketonic carbonyl group and the 
secondary amine group produced intense bands in the spectrum at 
1702.21 cm-1 and 3299.3 cm-1 regions respectively. In this study 
presence of these distinct bands was searched in the IR spectra of 
the samples. Result of IR analysis of the suspected samples was 
found congruent with HPLC analysis. 
Table 3: Results of Accuracy study for SC 
Recovery 
level 






Amount of  standard 
recovered (µgmL-1) 
% Recovery Mean of  %Recovery 
± %RSD* 
80% 
100 201.5 201.35 99.85 99.85 
99.97 ± 0.157 100 201.5 201.42 99.92 99.92 
100 201.5 201.65 100.15 100.15 
100% 
150 251.5 252.02 150.52 100.35 
100.04 ± 0.287 150 251.5 251.48 149.98 99.99 
150 251.5 251.17 149.67 99.78 
120% 
200 301.5 301.53 200.03 100.02 
100.00 ± 0.148 200 301.5 301.78 200.28 100.14 
200 301.5 301.19 199.69 99.85 
*Acceptance criteria < 2.0, Fixed sample concentration = 101.5 µgmL-1 
Table 4: Results of intraday and interday precision study for SC 
S. No. Concentration 
(μg/mL) 
Intra-day precision Inter-day precision 
Standard* Sample* Standard* Sample* 
1 250 5895276 5909364 5895346 5909868 
2 250 5915384 5937751 5915874 5937964 
3 250 5906275 5915483 5896753 5915297 
4 250 5935336 5896594 5935381 5895674 
5 250 5909247 5936754 5909349 5936374 
6 250 5927321 5895997 5927194 5895564 
Avg. 
 
5914807 5915324 5913316 5915124 
%RSD   0.247 0.314 0.273 0.317 
*Acceptance criteria for RSD of Peak Area < 2.0 
Table 5: Results of sensitivity study for SC 




LOQ 388 0.0535 
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Table 6: Results of Ruggedness study for SC 
                            Analyst-1                                    Analyst-2 
Sample No. Peak area* Sample No. Peak Area* 
1 5908946 1 5908873 
2 5938872 2 5928422 
3 5916983 3 5976938 
4 5893535 4 5892553 
5 5934771 5 5937417 
6 5895979 6 5895779 
Avg. 5914848 Avg. 5923330 
%RSD 0.323 %RSD 0.535 
*Acceptance criteria < 2.0 
 
Table 7: Results of Robustness study for SC 
Parameters Retention Time Tailing factor %RSD of Peak Area 
Mobile Phase Composition 
Acid : ACN = 62:38 7.097 1.325 0.594 
Acid : ACN = 58:42 7.208 1.384 0.582 
Flow rate 
0.3 11.834 1.372 0.387 
0.7 5.089 1.404 0.603 
Detection wavelength 
285 7.157 1.356 0.375 
295 7.151 1.368 0.353 
Column temperature 
25°C 7.216 1.349 0.437 
35°C 7.024 1..361 0.386 
*Acceptance criteria < 2.0 
 
Table 8: Quantitation of SC 
Sam. No. Type of dosage form SC content per dosage unit (mg)  ± SD # 
8 Tablet 15.86 ± 0.1 
9 Capsule 165.87 ± 0.073 
11 Capsule 20.52 ± 0.179 
12 Capsule 26.36 ± 0.172 
13 Syrup 99.59 ± 0.274 
26 Capsule 90.54 ± 0.252 
28 Capsule 151.74 ± 0.161 
29 Capsule 137.04 ± 0.117 
31 Capsule 131.4 ± 0.158 
33 Capsule 63.28 ± 0.133 
34 Tablet 67.7 ± 0.113 
35 Tablet 96.54 ± 0.154 
# Mean ± Standard deviation of 6 samples 
Table 9: Result of IR spectrum analysis of SC 
 
S. No. Functional group(s) Characteristic Absorption(s) range (cm-1) Identified in this study (cm-1) 
1 SO2 stretch 1200 - 1100 1172.74 
2 Aromatic C=C bond 1700 – 1500 1582.62 
3 C=O stretch 1750 – 1680 1702.21 
4 Saturated C–H stretch 2950 – 2850 2962.71 
5 Unsaturated C–H stretch 3100 - 3010 3029.26 
6 Secondary N-H stretch 3500 – 3300 3299.3 
7 O-H stretch 3550 – 3200 3617 
 
 
Fig. 3: HPLC chromatogram of (a) LOD of SC and (b) LOQ of SC. 
 
CONCLUSION 
About 35% of the total collected market samples were found to 
contain sildenafil without any labelling, which may be responsible 
for some of the reported benefits of these products. 20% (Sam. no. 8, 
9, 11, 12 and 13) of the traditional medicines and 70% (Sam. no. 26, 
28, 29, 31, 33, 34, and 35) of the dietary supplements were SC 
positive which indicates that the condition is even worse for dietary 
supplements. From the collected market samples around 11% of the 
samples (Sam. no. 9, 28, 29 and 31) were found that exceed the 
highest dose as per recommended. 
As this analytical work was conducted on a limited number of 
samples, this may not be an adequate reflection of the nature & 
number of falsifications actually prevailing in the market. Thus, this 
survey can be referred as an indicative or pilot study. The real 
situation might be more dangerous and thus further more analysis 
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will be required. More such analysis on different types of falsified 
products available in the market (such as drugs for obesity, weight 
gain, asthma etc.) is important to observe the trends and find out the 
risks. 
Government should take necessary steps to make people aware 
about these falsified products and formulate appropriate regulations 
to stop this type of unethical use of APIs. All the dietary supplements 
should be brought under the regulation of Drugs Administration and 
any kind of unjustified advertisements of traditional medicines and 
dietary supplements in mass media (newspaper, TV) should be 
brought under regulation like prescriptional drugs. 
All these measures are to be taken immediately to save public health, 
because these falsifications and hiding of facts is dangerous for the 
consumers due to the inherent serious adverse effects of the 








Fig. 4: IR spectrum of (a) standard SC, (b) sample no. 26, (c) 
sample no. 31 
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